Search Count: 74
![]() |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Release Date: 2025-08-20 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Structure Of Hiv-1 Bg505 Sosip.664 Env Trimer In Complex With Iomamin5 And 10-1074 Broadly Neutralizing Antibodies - Class I
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-05-21 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Structure Of Hiv-1 Bg505 Sosip.664 Env Trimer In Complex With Iomamin5 And 10-1074 Broadly Neutralizing Antibodies - Class Ii
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-05-21 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-04-16 Classification: IMMUNE SYSTEM |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-04-16 Classification: Viral Protein/Immune System Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-04-16 Classification: Viral Protein/Immune System Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-04-16 Classification: Viral Protein/Immune System Ligands: NAG |
![]() |
Cryo-Em Structure Of The Bg505 Sosipv2 In Complex With Bnab 04_A06 And Pgdm1400 Fabs
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-04-16 Classification: Viral Protein/Immune System Ligands: NAG |
![]() |
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2024-09-04 Classification: IMMUNE SYSTEM Ligands: EDO |
![]() |
Organism: Human immunodeficiency virus 1, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2024-09-04 Classification: IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2023-03-01 Classification: ANTIVIRAL PROTEIN, IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2022-11-09 Classification: IMMUNE SYSTEM |
![]() |
Cryo-Em Structure Of Bg24 Fabs With An Inferred Germline Light Chain And 10-1074 Fabs In Complex With Hiv-1 Env Immunogen Bg505-Sosipv4.1-Gt1 Containing The N276 Gp120 Glycan- Class 1
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2022-11-09 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Cryo-Em Structure Of Bg24 Fabs With An Inferred Germline Cdrl1 And 10-1074 Fabs In Complex With Hiv-1 Env 6405-Sosip.664
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2022-11-09 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Cryo-Em Structure Of Bg24 Inferred Germline Fabs With Germline Cdr3S And 10-1074 Fabs In Complex With Hiv-1 Env Immunogen Bg505-Sosipv4.1-Gt1 - Class 1
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2022-10-26 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG, MAN |




















